Tekla Capital Management’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-89,200
| Closed | -$1.35M | – | 225 |
|
|
2019
Q4 | $1.35M | Buy |
+89,200
| New | +$770K | 0.05% | 173 |
|
|
2019
Q1 | – | Sell |
-161,579
| Closed | -$1.16M | – | 205 |
|
|
2018
Q4 | $1.16M | Sell |
161,579
-72,621
| -31% | -$795K | 0.05% | 157 |
|
|
2018
Q3 | $2.55M | Hold |
234,200
| – | – | 0.09% | 132 |
|
|
2018
Q2 | $2.15M | Hold |
234,200
| – | – | 0.08% | 135 |
|
|
2018
Q1 | $1.87M | Sell |
234,200
-34,300
| -13% | -$747K | 0.07% | 140 |
|
|
2017
Q4 | $7.47M | Sell |
268,500
-128,400
| -32% | -$3.4M | 0.29% | 67 |
|
|
2017
Q3 | $10.7M | Buy |
396,900
+10,000
| +3% | +$262K | 0.38% | 50 |
|
|
2017
Q2 | $11.3M | Buy |
386,900
+221,700
| +134% | +$6.74M | 0.42% | 54 |
|
|
2017
Q1 | $5.63M | Hold |
165,200
| – | – | 0.22% | 85 |
|
|
2016
Q4 | $5.01M | Buy |
165,200
+82,600
| +100% | +$2.66M | 0.21% | 79 |
|
|
2016
Q3 | $2.79M | Buy |
+82,600
| New | +$2.66M | 0.11% | 107 |
|
|
2015
Q3 | – | Sell |
-97,197
| Closed | -$1.71M | – | 173 |
|
|
2015
Q2 | $1.71M | Buy |
+97,197
| New | +$1.5M | 0.06% | 100 |
|
Tekla Capital Management's DERM Position: Q1 2020 in Review
Tekla Capital Management sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 89,200 shares — an estimated $1.35M sold.
Tekla Capital Management first reported a position in DERM in Q2 2015 and held it in 12 quarters. The position peaked at $11.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Tekla Capital Management reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Tekla Capital Management sold 89,200 Dermira, Inc. shares in Q1 2020, an estimated $1.35M.
- Tekla Capital Management first reported a position in Dermira, Inc. in Q2 2015 and held it in 12 quarters.
- Tekla Capital Management's Dermira, Inc. position peaked at $11.3M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Tekla Capital Management's 13F filing for Q1 2020, filed 14 May 2020.